← Back to headlines
Eli Lilly Gains as Medicare Expansion of GLP-1 Weight Loss Drugs Eases Pricing Concerns
Eli Lilly and Company (LLY) stock has risen due to the expansion of Medicare coverage for GLP-1 weight loss drugs, which has alleviated pricing concerns.
18 Feb, 15:13 — 18 Feb, 15:13
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Austrian Government's Anti-Inflation Measures Save Households 230 Euros Annually
just now
Best Interest-Bearing Savings Accounts for February 2026
just now
Latam assets firm but risk appetite shaky as US trade policy swerves - TradingView
14m ago
Treasuries Gain as Markets Rattled by Trump’s New Trade War - Bloomberg.com
14m ago